What’s your game?

What’s your game? Most of the businesses are becoming global and technology-driven, companies everywhere are

The devil’s in the detail

Commercial success of pharmaceutical products is subject to several risks, like reliance on third parties,

A damp squib

Dec 4th, 2020, in Neurim Pharmaceuticals (1991) Ltd & Anor v Generics UK Ltd (t\a

Stand your Ground

On Nov. 30, 2020, the US District Court for the District of Delaware on remand

Pay for Delay

Nov 2020, the European Commission (EC) has fined Teva and its now subsidiary Cephalon 60.5

Drain the swamp

The Biologics Price Competition and Innovation Act of 2009 (BPCI Act) established a framework for

Hop, hop, hop…..

The introduction of modified versions of original products, is used as a strategy by pharmaceutical

The opposite of “more”

Focus of generic pharmaceutical company is mainly on navigating the innovator’s intellectual property and not